Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial
Sign Up to like & getrecommendations! Published in 2020 at "The Lancet"
DOI: 10.1016/s0140-6736(20)30609-7
Abstract: BACKGROUND Vitiligo is a chronic autoimmune disease resulting in skin depigmentation and reduced quality of life. There is no approved treatment for vitiligo repigmentation and current off-label therapies have limited efficacy, emphasising the need for… read more here.
Keywords: daily group; twice daily; treatment; ruxolitinib cream ... See more keywords
Rapid pruritus reduction with ruxolitinib cream treatment in patients with atopic dermatitis
Sign Up to like & getrecommendations! Published in 2022 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.18571
Abstract: Ruxolitinib cream is a topical formulation of ruxolitinib, a Janus kinase (JAK) 1/JAK2 inhibitor. read more here.
Keywords: ruxolitinib; ruxolitinib cream; pruritus reduction; rapid pruritus ... See more keywords
Management of Atopic Dermatitis: Clinical Utility of Ruxolitinib
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Asthma and Allergy"
DOI: 10.2147/jaa.s342051
Abstract: Abstract Atopic dermatitis (AD) is a common chronic, pruritic inflammatory skin disease that profoundly impacts patients’ quality of life. As the first FDA-approved topical JAK inhibitor, ruxolitinib 1.5% cream represents a novel therapeutic topical agent… read more here.
Keywords: ruxolitinib; atopic dermatitis; ruxolitinib cream; management atopic ... See more keywords
Ruxolitinib Cream Has Dual Efficacy on Pruritus and Inflammation in Experimental Dermatitis
Sign Up to like & getrecommendations! Published in 2020 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2020.620098
Abstract: The goal of this study was to elucidate the anti-pruritic and anti-inflammatory efficacy of ruxolitinib cream in experimentally-induced dermatitis. Atopic dermatitis (AD), the most common chronic relapsing inflammatory skin disease, significantly impairs patients’ quality of… read more here.
Keywords: dermatitis; ruxolitinib cream; inflammation; efficacy ... See more keywords